Breast cancer but not the menopausal status is associated with small changes of the gut microbiota/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-6-13

Curated date: 2024/03/24

Curator: Keamy

Revision editor(s): Keamy, Scholastica, WikiWorks

Subjects

Location of subjects
Poland
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Breast cancer breast cancer,breast tumor,cancer of breast,malignant breast neoplasm,malignant breast tumor,malignant neoplasm of breast,malignant neoplasm of the breast,malignant tumor of breast,malignant tumor of the breast,mammary cancer,mammary neoplasm,mammary tumor,primary breast cancer,Breast cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
pre-menopausal controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
pre-menopausal breast cancer (BC) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Newly diagnosed pre- or perimenopausal breast cancer patients at the Maria Sklodowska-Curie National Research Institute of Oncology.
Group 0 sample size Number of subjects in the control (unexposed) group
51
Group 1 sample size Number of subjects in the case (exposed) group
47
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
2 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-13

Curated date: 2024/03/31

Curator: Keamy

Revision editor(s): Keamy, Scholastica, WikiWorks

Source: Table 3

Description: Taxa differentiating premenopausal breast cancer (BC) patients from premenopausal controls assessed using the LInear model for Differential Abundance (LINDA) method for compositional data

Abundance in Group 1: increased abundance in pre-menopausal breast cancer (BC) patients

NCBI Quality ControlLinks
Actinomycetaceae
Actinomycetota
Anaeromassilibacillus
Bifidobacteriaceae
Bifidobacterium
Coriobacteriaceae
Eggerthellaceae
Gemmiger
Gemmiger formicilis
Ruthenibacterium
[Collinsella] massiliensis

Revision editor(s): Keamy, Scholastica, WikiWorks